The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014.

about

European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition.Metabolic control, anticoagulation, and gender aspects.Risk Factors, Co-Morbidities and Treatment of In-Hospital Patients with Atrial Fibrillation in Bulgaria

P2860

Q48714148-4C6470A9-C632-44DE-9F8C-11A0FB80F088 Q50235296-BFB392B0-10AB-453D-9A3F-0FAE9E11C85E Q57825501-54012555-EE4C-42AD-9BF5-750633F46EA6

P2860

The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014.

Item

http://www.wikidata.org/entity/Q36860614

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The evolving landscape of oral ...... llation in England: 1998-2014.

@en

type

Item

label

The evolving landscape of oral ...... llation in England: 1998-2014.

@en

prefLabel

The evolving landscape of oral ...... llation in England: 1998-2014.

@en

P1476

The evolving landscape of oral ...... llation in England: 1998-2014.

@en

P2093

Alexander R Lyon

http://www.w3.org/2001/XMLSchema#string

Carl Hayward

http://www.w3.org/2001/XMLSchema#string

Carlo Di Mario

http://www.w3.org/2001/XMLSchema#string

Edward Rowland

http://www.w3.org/2001/XMLSchema#string

Hitesh C Patel

http://www.w3.org/2001/XMLSchema#string

Ketna Patel

http://www.w3.org/2001/XMLSchema#string

Syed Y Ahsan

http://www.w3.org/2001/XMLSchema#string

P2860

The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS

Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation

An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation

Effect of dronedarone on cardiovascular events in atrial fibrillation

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

Increased mortality after dronedarone therapy for severe heart failure

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

Dronedarone in High-Risk Permanent Atrial Fibrillation

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)

P304

90-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EHJCVP/PVV048

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284754966

http://www.w3.org/2001/XMLSchema#string

P698

27418969

http://www.w3.org/2001/XMLSchema#string

P932

4853827

http://www.w3.org/2001/XMLSchema#string

The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014.

about

P2860

P2860

The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932